Cargando…
Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
Triple negative breast cancer (TNBC) is an aggressive subtype with relatively poor clinical outcomes and limited treatment options. Chemotherapy, while killing cancer cells, can result in the generation of highly chemoresistant therapeutic induced senescent (TIS) cells that potentially form stem cel...
Autores principales: | Kavanagh, E L, Lindsay, S, Halasz, M, Gubbins, L C, Weiner-Gorzel, K, Guang, M H Z, McGoldrick, A, Collins, E, Henry, M, Blanco-Fernández, A, Gorman, P O', Fitzpatrick, P, Higgins, M J, Dowling, P, McCann, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668881/ https://www.ncbi.nlm.nih.gov/pubmed/28991260 http://dx.doi.org/10.1038/oncsis.2017.82 |
Ejemplares similares
-
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells
por: Weiner-Gorzel, Karolina, et al.
Publicado: (2015) -
The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)
por: Howard, Jane, et al.
Publicado: (2021) -
The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015) -
miR-433 overexpression attenuates the spindle assembly checkpoint response to paclitaxel
por: Furlong, F, et al.
Publicado: (2010) -
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro
por: Prencipe, M, et al.
Publicado: (2010)